Nina F. Schor | Academic Influence

Nina F. Schor's AcademicInfluence.com Rankings

Nina F. Schor

Medical

#1613

World Rank

#1971

Historical Rank

#407

USA Rank

Pediatrics

#92

World Rank

#106

Historical Rank

#22

USA Rank

medical Degrees

Download Badge

Medical

Nina F. Schor's Degrees

Bachelors Biology University of Pennsylvania

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Nina F. Schor Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Nina Felice Schor is an American physician-scientist and pediatric neurologist. She has served as director of the NIH Intramural Research Program since the Fall of 2022. Schor was the deputy director of National Institute of Neurological Disorders and Stroke from 2018 to 2022. She was the William H. Eilinger Chair of the Department of Pediatrics at University of Rochester and Pediatrician-in-Chief of the Golisano Children’s Hospital from 2006 to January 2018.

(See a Problem?)

Nina F. Schor's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Whole-Body Hypothermia for Neonates With Hypoxic–Ischemic Encephalopathy (2007) (602)
Apoptosis in the absence of caspase 3 (2001) (239)
Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis (2000) (175)
Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. (2000) (121)
What the halted phase III γ‐secretase inhibitor trial may (or may not) be telling us (2011) (106)
The p75 neurotrophin receptor in human development and disease (2005) (98)
Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells. (1997) (89)
Nerve Growth Factor (NGF)-Mediated Protection of Neural Crest Cells from Antimitotic Agent-Induced Apoptosis: The Role of the Low-Affinity NGF Receptor (1996) (86)
Swaiman's Pediatric Neurology: Principles and Practice (2017) (85)
Inactivation of mammalian brain glutamine synthetase by oxygen radicals (1988) (74)
The Endoplasmic Reticulum Stress Response Factor CHOP-10 Protects against Hypoxia-induced Neuronal Death (2010) (66)
The Decanal Divide: Women in Decanal Roles at U.S. Medical Schools (2017) (60)
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease (2008) (59)
Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2. (2002) (53)
Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. (2005) (51)
Interaction between 6-hydroxydopamine and transferrin: "Let my iron go". (2000) (49)
The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder (2016) (49)
The Scholarly Project Initiative: Introducing Scholarship in Medicine through a Longitudinal, Mentored Curricular Program (2005) (48)
Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants. (1995) (47)
Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain (2007) (46)
Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2. (1996) (44)
Presenilin-1-Dependent Transcriptome Changes (2005) (43)
Neuroblastoma as a Neurobiological Disease (2004) (43)
TrkA as a life and death receptor: receptor dose as a mediator of function. (2002) (41)
Bobble-head doll syndrome and drop attacks in a child with a cystic choroid plexus papilloma of the third ventricle. Case report. (1995) (41)
Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo (2010) (36)
Cell line dependence of Bcl-2-induced alteration of glutathione handling (2000) (36)
p75-nerve growth factor as an antiapoptotic complex: independence versus cooperativity in protection from enediyne chemotherapeutic agents. (2002) (35)
Neural Crest Development (2002) (34)
Loss of c/EBP-β activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons (2008) (32)
The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress (2005) (30)
DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes (2003) (28)
Bcl-2 mediates induction of neural differentiation (2003) (28)
Pharmacologic Management of High-Risk Neuroblastoma in Children (2011) (28)
Toward the definition of acute disseminated encephalitis of childhood (2004) (28)
Selective oxidation and externalization of membrane phosphatidylserine: Bcl-2-induced potentiation of the final common pathway for apoptosis (1999) (27)
Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells: role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. (1998) (26)
Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells. (2005) (26)
P75 neurotrophin receptor regulates expression of neural cell adhesion molecule 1 (2005) (26)
Anticipatory guidance as a principle of faculty development: managing transition and change. (2011) (25)
Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy. (1987) (24)
Effects of pH on the cytotoxicity of sodium trioxodinitrate (Angeli's salt). (2004) (23)
Oxidation and cytotoxicity of 6-OHDA are mediated by reactive intermediates of COX-2 overexpressed in PC12 cells (2006) (23)
Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease. (1997) (23)
p75NTR‐dependent modulation of cellular handling of reactive oxygen species (2009) (22)
In-tube transfection improves the efficiency of gene transfer in primary neuronal cultures (2009) (21)
Pharmacotherapy for adults with tumors of the central nervous system. (2009) (21)
Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol. (1996) (20)
Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine. (1988) (19)
Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage. (1996) (19)
Cerebellar Glutamine Synthetase in Children After Hypoxia or Ischemia (1991) (19)
Formation of Nitroxyl and Hydroxyl Radical in Solutions of Sodium Trioxodinitrate (2003) (19)
Differential membrane antioxidant effects of immediate and long-term estradiol treatment of MCF-7 breast cancer cells. (1999) (19)
Transcriptome differences between the frontal cortex and hippocampus of wild-type and humanized presenilin-1 transgenic mice. (2005) (18)
Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma (2016) (18)
Neurology of systemic autoimmune disorders: a pediatric perspective. (2000) (17)
Early events in Bcl-2-enhanced apoptosis (2003) (17)
Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin. (1995) (17)
New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. (2009) (17)
Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA (2004) (16)
Clinical Pediatric Neurology: A Signs and Symptoms Approach, 3rd ed. (1997) (16)
Cerebellar Purkinje cell p75 neurotrophin receptor and autistic behavior (2014) (16)
Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells. (1992) (16)
PRMT1 promotes neuroblastoma cell survival through ATF5 (2020) (15)
FTY720 impairs necrosis development after ischemia-reperfusion injury. (2004) (15)
Topical Review Article: Nervous System Dysfunction in Children With Paraneoplastic Syndromes (1992) (15)
Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture. (1989) (14)
Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model. (2013) (13)
The child is father to the man: Developmental roles for proteins of importance for neurodegenerative disease (2010) (13)
The roles of mitotic arrest and protein synthesis in induction of apoptosis and differentiation in neuroblastoma cells in culture. (1998) (13)
The supportive academic environment: ingredients for success. (2003) (12)
Adult neurology training during child neurology residency (2012) (12)
Comprar Swaiman's Pediatric Neurology, 5th Edition. Principles and Practice, 2-Volume Set | Nina Schor | 9781437704358 | Saunders (2012) (11)
Kidins220/ARMS is expressed in neuroblastoma tumors and stabilizes neurotrophic signaling in a human neuroblastoma cell line (2013) (11)
Nelson textbook of pediatrics. Volume 2 (2016) (11)
Structural studies on the inactivation of gamma-glutamylcysteine synthetase by the disulphide analogues of radioprotective cysteamine derivatives. Effects of aminoalkyl and hydroxyalkyl chain length and beta beta-bis-dimethylation. (1990) (11)
Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy (2008) (11)
Prevention of neocarzinostatin-induced cell death and morphologic change in SK-N-SH human neuroblastoma cells by continuous exposure to nerve growth factor. (1993) (10)
p75NTR: an enhancer of fenretinide toxicity in neuroblastoma (2013) (10)
Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2 (2006) (10)
Exploiting Oxidative Stress and Signaling in Chemotherapy of Resistant Neoplasms (2004) (10)
Brain imaging and prophylactic therapy in children with migraine: recommendations versus reality. (2003) (10)
Botulism (Clostridium Botulinum) (2011) (9)
Necdin and Neurotrophin Receptors: Interactors of Relevance for Neuronal Resistance to Oxidant Stress (2011) (9)
Depletion of glutathione by the radioprotective agent S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR2721). (1988) (9)
Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress. (2009) (9)
EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markers (2016) (8)
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy (2008) (8)
Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor (2009) (8)
Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma (2018) (7)
Chopper Is Prodeath Regardless of the Effect of p75ICD on Sensitivity to Oxidative Stress (2011) (7)
Why our patients (and we) need basic science research (2013) (7)
Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary (2021) (7)
Using Chemistry to Target Neuroblastoma. (2017) (7)
Bcl-2 overexpression disrupts the morphology of PC12 cells through reduced ERK activation (2006) (6)
Phosphatidylserine peroxidation during apoptosis (2004) (6)
p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma (2014) (6)
Neuroblastoma: A Neurochemical Approach (1991) (6)
Proposed Criteria for Referral and Evaluation of Children for Epilepsy Surgery: Recommendations of the Subcommission for Pediatric Epilepsy SurgeryCross JH, for the International League Against Epilepsy Subcommission for Paediatric Epilepsy Surgery, and the Commissions of Neurosurgery and Paediatric (2007) (5)
Neurodevelopmental Clues to Neurodegeneration (2021) (5)
Signal transduction for clinicians: why should we care? (2001) (5)
Aiming at Neuroblastoma and Hitting Other Worthy Targets (2013) (5)
Developmental Arrest (2008) (4)
Swaiman's Pediatric Neurology, 5th Edition. Principles and Practice, 2-Volume Set (2012) (4)
Brain glutamine synthetase activity and hyperoxia in neonatal rats (1991) (4)
p75NTR enhances PC12 cell tumor growth by a non-receptor mechanism involving downregulation of cyclin D2. (2006) (4)
Life at the interface: Adults with “pediatric” disorders of the nervous system (2013) (4)
Seeking progress in disease modification in Parkinson disease. (2021) (4)
Induction of Expression of p75 Neurotrophin Receptor Intracellular Domain Does Not Induce Expression or Enhance Activity of Mitochondrial Complex II (2015) (3)
Treatment with propofol (2005) (3)
The Role of p75NTR and Its Signaling Pathways in Fenretinide (4HPR)-Induced Apoptosis in Neuroblastoma Cells (P06.003) (2012) (3)
NINDS launches network to develop treatments for ultra-rare neurological diseases (2021) (3)
Women in medical school leadership positions: Implications for research (2019) (3)
Comment: Autonomy vs beneficence (2014) (3)
Nonconvulsive Seizures in the Pediatric Intensive Care Unit: Etiology, EEG, and Brain Imaging Findings (2008) (3)
Phosphatidylserine peroxidation during apoptosis. A signaling pathway for phagocyte clearance. (2002) (3)
Inactivation of γ-Glutamylcysteine Synthetase by SAPH-3 Disulfide: Role of the Histaminyl Moiety (1991) (2)
Pursuit and achievement of leadership: A view from the top (2014) (2)
Targeting Vitamin-D receptor (VDR) by a small molecule antagonist MeTC7 inhibits PD-L1 but controls THMYCN neuroblastoma growth PD-L1 independently (2020) (2)
The Electronic Medical Record and Computerized Physician Order Entry: Challenges and Opportunities for Pediatrics. (2016) (2)
Neuronal ‘differentiation’ of murine neuroblastoma cells induced by neocarzinostatin: neural cell adhesion molecules (1993) (2)
Personal health information in verse (2013) (2)
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective studyRolfs A, Böttcher T, Zschiesche M, et al (Univ of Rostock, Germany; Univ of Tübingen, Germany; Univ College London; et al) Lancet 366:1794–1796, 2005§ (2007) (2)
Pediatric residency preceding child neurology training. (2011) (2)
Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells (2015) (2)
Topical Review: Whimpers and Bangs: Of Death and Dying in the Nervous System (1998) (2)
A Neurologist's Approach to Neuroblastoma (1992) (2)
Effects of neocarzinostatin upon the development of tumors from murine neuroblastoma cells (2004) (2)
Abstract 464: Methylase meets phosphatase: roles of PRMT and EYA1 in neuroblastoma (2014) (2)
Cerebellar Purkinje cell p75 neurotrophin receptor and autistic behavior (2014) (2)
Building a Division of Child Neurology: A Tribute to Michael J. Painter, MD (2003) (1)
Current Pharmacotherapy for Neuroblastoma (2019) (1)
Pediatric neurohospitalists (2013) (1)
Neuroblastoma as a Clinical Entity (2002) (1)
Migraine with Aura Is a Risk Factor for Unprovoked Seizures in ChildrenLudvigsson P, Hesdorffer D, Olafsson E, et al (Landspitalinn Univ, Reykjavik, Iceland; GH Sergievsky Ctr, New York; Columbia Univ, New York) Ann Neurol 59:210–213, 2006§ (2007) (1)
Crossroads: Two Points of View: RESPONSE (2008) (1)
The Neurology of Neuroblastoma (2002) (1)
Methylation of the phosphatase‐transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies (2017) (1)
Dyskinesias and Associated Psychiatric Disorders Following Streptococcal InfectionsDale RC, Heyman I, Surtees RAH, et al (Inst of Child Health, London) Arch Dis Child 89:604–610, 2004§ (2006) (1)
The NINDS 2021–2026 Strategic Plan: Partnership and cross-cutting principles (2022) (1)
Saving neurology (2019) (1)
Autism today (2017) (1)
Phosphatidylserine signaling in apoptosis (1998) (1)
Neurodevelopmental Outcomes of Premature Infants Treated With Inhaled Nitric OxideMestan KKL, Marks JD, Hecox K, et al (Univ of Chicago) N Engl J Med 353:23–32, 2005§ (2007) (1)
Programmatic Foci of Women in Academic Leadership Positions at Historically Black Colleges and Universities: Intersectionality and Institutional Mission (2021) (1)
Child neurologists and neurodevelopmental disabilities physicians (2016) (1)
Diversifying Child Neurology: Developing a Workforce That Reflects the Patients and Families for Whom We Care. (2020) (1)
Author response: Saving neurology: Once more with feeling (2020) (1)
121 – Neurologic Manifestations of Rheumatic Disorders of Childhood (2017) (1)
Current Pharmacotherapy for Neuroblastoma (2019) (1)
Essential Tremor Among Children (2006) (0)
SUBJECT: NINDS strategic plan planning process input from national organized neurological surgical organizations Dear Dr. Schor: On behalf of the American Academy of Neurological Surgeons (AAcNS), American Association of Neurological Surgeons (AANS), American Board of Neurological Surgery (ABNS), Co (2019) (0)
Robert J. Joynt, MD, PhD (2012) (0)
Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteinsMuntoni F, Bonne G, Goldfarb LG, et al (Imperial College, London; Royal Veterinary College, Hertfordshire, England; Harefield Hosp, England; et al) Brain 129:1260–1268, 2006§ (2007) (0)
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo (2022) (0)
PRMT1 promotes neuroblastoma cell survival through ATF5. Oncogenesis, (2020) (0)
Academic Neurology and the COVID-19 Pandemic (2022) (0)
Textbook of Pediatrics (1950) (0)
Prothrombotic Factors in Children With Stroke or PorencephalyLynch JK, Han CJ, Nee LE, et al (Natl Inst of Neurological Disorders and Strokes, Bethesda, Md) Pediatrics 116:447–453, 2005§ (2007) (0)
Neurology Year-in-review—Pediatric Neurology (2015) (0)
Surgery for Epilepsy Due to Cortical Malformations: Ten-year FollowupHamiwka L, Jayakar P, Resnick T, et al (Alberta Children's Hosp, Calgary, Canada; Miami Children's Hosp; Fla; Univ of Miami, Fla) Epilepsia 46:556–560, 2005§ (2007) (0)
Abstract B22: Antitumor effects of selective PRMT1 inhibitors on neuroblastoma in vitro and in vivo (2018) (0)
Introductory address for the John Howland Award recipient, Elizabeth R. McAnarney, MD (2013) (0)
Reflections: neurology and the humanities: personal health information in verse. (2013) (0)
List of Contributors (2019) (0)
Preface to the Fifth Edition (2012) (0)
Apoptosis in the Nervous System (2002) (0)
Neurooncology and Cancer Therapy (1998) (0)
Brain Mets (2006) (0)
Career equity in medicine (2021) (0)
G-protein expression during enediyne-induced neurite outgrowth in neuroblastoma (1995) (0)
Child neurology: A trilogy (2006) (0)
The Nervous System PART XXVI (0)
Acute Disseminated Encephalomyelitis in Children: Discordant Neurologic and Neuroimaging Abnormalities and Responses to Plasmapheresis (2007) (0)
Lupus Anticoagulant and Stroke-Reply (1987) (0)
ENDOGENOUS ANTI-APOPTOSIS PROTEINS: CONTRIBUTORS TO THE CHEMOTHERAPEUTIC RESISTANCE OF NEUROBLASTOMA. † 957 (1996) (0)
Reflections: Neurology and the Humanities (2006) (0)
A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine (2007) (0)
Inactivation of gamma-glutamylcysteine synthetase by SAPH-3 disulfide: role of the histaminyl moiety. (1991) (0)
Planning and Implementing Strategically (2022) (0)
Reflections for May (2010) (0)
NINDS strategic plan planning process input from national organized neurological surgical organizations (2019) (0)
Knockout of p75NTR in Cerebellar Purkinje Cells Results in an Autism-like Murine Phenotype (P4.337) (2014) (0)
Vagus nerve stimulation: Clinical experience in drug-resistant pediatric epileptic patients (2008) (0)
Crossroads: Two Points of View: RESIDENT WORK HOURS: ISOLATING ONE LEDGER COLUMN AND MISSING THE POINT (2008) (0)
Year-in-review — Pediatric Neurology (0)
A Life at the Interface: The 2017 Hower Award Lecture. (2017) (0)
Poems (2008) (0)
P4-277 The role of PS1 in P75 signaling (2004) (0)
Job negotiation (2017) (0)
The NIH Intramural Research Program: Opportunities for training and career development in neuroscience and beyond (2023) (0)
Paraneoplastic Syndromes and Neuroblastoma (2002) (0)
Proceedings of the First Pediatric Coma and Disorders of Consciousness Symposium by the Curing Coma Campaign, Pediatric Neurocritical Care Research Group, and NINDS: Gearing for Success in Coma Advancements for Children and Neonates (2023) (0)
Author response. (2015) (0)
Reflections for January (2010) (0)
Reflections: neurology and the humanities. Prayer (dement me not). (2010) (0)
The Way It Unfortunately Is (2014) (0)
The continuing challenges facing gene-targeted therapies. (2023) (0)
A Single Episode of Neonatal Seizures Permanently Alters Glutamatergic Synapses (2008) (0)
Exploiting BCL-2 Overexpression in the Chemotherapy of Breast Cancer (1998) (0)
Chance juxtapositions and (un)biased methods in science (2017) (0)
Right of First Refusal (2018) (0)
Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis (2007) (0)
Toward a Smoother Rocky Road. (2020) (0)
P4-266 Brain transcriptome changes in presenilin-1 mutant mice (2004) (0)

This paper list is powered by the following services:

Other Resources About Nina F. Schor

en.wikipedia.org

What Schools Are Affiliated With Nina F. Schor?

Nina F. Schor is affiliated with the following schools: